Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

As the clinical research landscape evolves, decentralized clinical trials (DCTs) have emerged as a foundational competency, ...

Digital health technologies are transforming respiratory medicine, enhancing home monitoring and enabling decentralized clinical trials in resource-limited settings. The Panacea framework evaluates ...

"New BCC Research analysis projects 13.7% CAGR, driven by regulatory momentum, AI integration and the push for greater ...

Peer-reviewed randomized controlled study by People Science and Mimio Health, published in Nature Scientific Reports LOS ANGELES, March 2, 2026 /PRNewswire/ -- People Science today announced the ...

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical trials, or DCTs. Unlike traditional trials that require participants to visit ...

Over the past few years, we’ve seen a wave of digital innovation in clinical trials: decentralized models, eConsent, real-time monitoring and direct-to-patient logistics. We’ve digitized nearly every ...

Key opportunities include expanding cloud-based platforms, leveraging interventional and oncology trials, targeting ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field – now generally referred to as "decentralized clinical trials" – has been advancing and gaining ...